Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

NCT05570188 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The PI decides to stop.

Conditions

B-cell Lymphoma
B-cell Leukemia

Interventions

BIOLOGICAL: anti-CD19 UCAR-NK cells

Sponsor

Kunming Hope of Health Hospital